These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7734776)

  • 1. [Effect of the association of antimitotic agents on cell lines of human adenocarcinoma].
    Garcia P; Braguer D; Carles G; Briand C
    Bull Cancer; 1994 Oct; 81(10):900-2. PubMed ID: 7734776
    [No Abstract]   [Full Text] [Related]  

  • 2. Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents.
    Hida T; Kozaki K; Ito H; Miyaishi O; Tatematsu Y; Suzuki T; Matsuo K; Sugiura T; Ogawa M; Takahashi T; Takahashi T
    Clin Cancer Res; 2002 Jul; 8(7):2443-7. PubMed ID: 12114451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy.
    Andres R; Mayordomo JI; Isla D; Marti JL; Escudero P; Filipovich E; Saenz A; Alvarez I; Polo E; Tres A
    Br J Cancer; 2002 Mar; 86(6):1017-8. PubMed ID: 11953839
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials of new anticancer agents in recent years in China.
    Sun Y
    Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():86-7. PubMed ID: 11890120
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapy for prostate cancers].
    Naito K
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():205-10. PubMed ID: 12599572
    [No Abstract]   [Full Text] [Related]  

  • 6. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with paclitaxel/carboplatin chemotherapy in advanced adenocarcinoma of the urinary tract producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125.
    Kato M; Onishi T; Hoshina A; Yabana T
    Urol Int; 2010; 84(1):116-8. PubMed ID: 20173382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines.
    Aoe K; Kiura K; Ueoka H; Tabata M; Matsumura T; Chikamori M; Matsushita A; Kohara H; Harada M
    Anticancer Res; 1999; 19(1A):291-9. PubMed ID: 10226557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NICE recommends new treatment for breast and bowel cancer.
    Mayor S
    BMJ; 2003 May; 326(7400):1166. PubMed ID: 12775610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Taxotere in various solid tumors].
    Orel NF
    Vopr Onkol; 1998; 44(5):639-44. PubMed ID: 9925501
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined effect of docetaxel and cisplatin for non-small cell lung cancer cell lines in vitro.
    Wang H
    Nagoya J Med Sci; 2000 Nov; 63(3-4):129-37. PubMed ID: 11201987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy with orally administered UFT and leucovorin (LV)].
    Okabe H; Saito H; Oie S; Nakano K; Uchida J; Takechi T; Takeda S; Kawaguchi Y; Taguchi T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1645-50. PubMed ID: 1872623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of paclitaxel in combination with cisplatin and a new Pt-mercaptopyridine complex.
    Ragazzi E; D'Ancona S; Berti E; Carrara M
    Anticancer Res; 2002; 22(5):2783-8. PubMed ID: 12529997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.
    Sirotnak FM; Zakowski MF; Miller VA; Scher HI; Kris MG
    Clin Cancer Res; 2000 Dec; 6(12):4885-92. PubMed ID: 11156248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinflunine potentiates the activity of cisplatin but not 5-fluorouracil in a transplantable murine adenocarcinoma model.
    Shnyder SD; Cooper PA; Gyselinck N; Hill BT; Double JA; Bibby MC
    Anticancer Res; 2003; 23(6C):4815-20. PubMed ID: 14981930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical profile of docetaxel (taxotere): efficacy as a single agent and in combination.
    Bissery MC; Vrignaud P; Lavelle F
    Semin Oncol; 1995 Dec; 22(6 Suppl 13):3-16. PubMed ID: 8604451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel in the management of advanced non-small cell lung cancer.
    Miller VA
    Semin Oncol; 1998 Jun; 25(3 Suppl 8):15-9. PubMed ID: 9704671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer.
    Krug LM; Miller VA
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):24-6; discussion 41-2. PubMed ID: 10585005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.
    Kourousis C; Androulakis N; Kakolyris S; Souglakos J; Maltezakis G; Metaxaris G; Chalkiadakis G; Samonis G; Vlachonikolis J; Georgoulias V
    Cancer; 1998 Nov; 83(10):2083-90. PubMed ID: 9827712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.